One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Oral immediate-release source; do not transfer to IV or extended-release minocycline. Historical infection regimens are not current preferred-therapy determinations.
The MINOCIN IV label sets a renal-impairment ceiling of 200 mg per 24 hours. UCSF lists a 200-mg loading dose followed by 100 mg every 12 hours without renal adjustment, and selected higher-dose treatment with specialist input. Initial-day exposure or high-dose maintenance can exceed the label ceiling.
What to reconcile: This is a real exposure difference, not just alternate wording. Obtain infectious-disease/antimicrobial-stewardship input and document the exact IV product, indication, renal status, total first-day exposure and monitoring before choosing an approach. Do not silently merge the label cap with an institutional schedule.
Open this note and its source referencesAdults receive 200 mg IV/orally once, then 100 mg every 12 hours. UCSF makes no routine renal or hemodialysis reduction. Some selected infections may require 200 mg every 12 hours with ID/stewardship input.
This higher-dose expert strategy must be distinguished from product-label renal cautions and total-daily-dose limits. Do not apply it to extended-release acne products, topical products or an unreviewed formulation.
RDM30-044-minocycline-1 · Source locator: UCSF - systemic minocycline institutional strategy; renal/dosing sections and stated qualifiers
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=minocycline&s1=RDM30-044-minocycline&h1=98ceaa753c6fa6b622d0d5c8a1fe327a7ce06e3cc1c61012cebec7c34798993f